For example, METTL3 has been found to play a role in the progression of colorectal cancer by targeting the m6A-BHLHE41-CXCL1/CXCR2 axis, resulting in the inhibition of antitumor immunity [36]. Here, CXCR2 is linked to colorectal cancer.